Literature DB >> 24338009

The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

Nataly P Podolnikova1, Sergiy Yakovlev, Valentin P Yakubenko, Xu Wang, Oleg V Gorkun, Tatiana P Ugarova.   

Abstract

The currently available antithrombotic agents target the interaction of platelet integrin αIIbβ3 (GPIIb-IIIa) with fibrinogen during platelet aggregation. Platelets also bind fibrin formed early during thrombus growth. It was proposed that inhibition of platelet-fibrin interactions may be a necessary and important property of αIIbβ3 antagonists; however, the mechanisms by which αIIbβ3 binds fibrin are uncertain. We have previously identified the γ370-381 sequence (P3) in the γC domain of fibrinogen as the fibrin-specific binding site for αIIbβ3 involved in platelet adhesion and platelet-mediated fibrin clot retraction. In the present study, we have demonstrated that P3 can bind to several discontinuous segments within the αIIb β-propeller domain of αIIbβ3 enriched with negatively charged and aromatic residues. By screening peptide libraries spanning the sequence of the αIIb β-propeller, several sequences were identified as candidate contact sites for P3. Synthetic peptides duplicating these segments inhibited platelet adhesion and clot retraction but not platelet aggregation, supporting the role of these regions in fibrin recognition. Mutant αIIbβ3 receptors in which residues identified as critical for P3 binding were substituted for homologous residues in the I-less integrin αMβ2 exhibited reduced cell adhesion and clot retraction. These residues are different from those that are involved in the coordination of the fibrinogen γ404-411 sequence and from auxiliary sites implicated in binding of soluble fibrinogen. These results map the binding of fibrin to multiple sites in the αIIb β-propeller and further indicate that recognition specificity of αIIbβ3 for fibrin differs from that for soluble fibrinogen.

Entities:  

Keywords:  Adhesion; Clot Retraction; Fibrin; Fibrinogen; Integrin; Platelets

Mesh:

Substances:

Year:  2013        PMID: 24338009      PMCID: PMC3900980          DOI: 10.1074/jbc.M113.518126

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.

Authors:  S Yakovlev; E Makogonenko; N Kurochkina; W Nieuwenhuizen; K Ingham; L Medved
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

2.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.

Authors:  Z Yang; I Mochalkin; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3).

Authors:  W Puzon-McLaughlin; T Kamata; Y Takada
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

4.  Fibrin clot retraction by human platelets correlates with alpha(IIb)beta(3) integrin-dependent protein tyrosine dephosphorylation.

Authors:  S Osdoit; J P Rosa
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller model.

Authors:  T Kamata; K K Tieu; A Irie; T A Springer; Y Takada
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

Review 6.  Platelet-fibrinogen interactions.

Authors:  J S Bennett
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

7.  EDTA-induced changes in platelet structure and function: clot retraction.

Authors:  J G White
Journal:  Platelets       Date:  2000-02       Impact factor: 3.862

Review 8.  The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors:  Barry S Coller; Sanford J Shattil
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

9.  Folding and function of I domain-deleted Mac-1 and lymphocyte function-associated antigen-1.

Authors:  P Yalamanchili; C Lu; C Oxvig; T A Springer
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

10.  Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib.

Authors:  G Soslau; R Class; D A Morgan; C Foster; S T Lord; P Marchese; Z M Ruggeri
Journal:  J Biol Chem       Date:  2001-03-30       Impact factor: 5.157

View more
  19 in total

1.  Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.

Authors:  Nadine J A Mattheij; Frauke Swieringa; Tom G Mastenbroek; Michelle A Berny-Lang; Frauke May; Constance C F M J Baaten; Paola E J van der Meijden; Yvonne M C Henskens; Erik A M Beckers; Dennis P L Suylen; Marc W Nolte; Tilman M Hackeng; Owen J T McCarty; Johan W M Heemskerk; Judith M E M Cosemans
Journal:  Haematologica       Date:  2015-12-31       Impact factor: 9.941

Review 2.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

3.  αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible.

Authors:  Hina Zafar; Yi Shang; Jihong Li; George A David; Joseph P Fernandez; Henrik Molina; Marta Filizola; Barry S Coller
Journal:  Blood Adv       Date:  2017-02-22

4.  Congenital hypodysfibrinogenemia associated with a novel deletion of three residues (γAla289_Asp291del) in fibrinogen.

Authors:  Liqing Zhu; Misheng Zhao; Mingshan Wang; Zhefeng Lou; Xiaoli Chen; Liangliang Pan; Dandan Yu; Wenli Xia; Han Wang; Bin Zhou; Shenmeng Gao
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

5.  Fibrin and D-dimer bind to monomeric GPVI.

Authors:  Marie-Blanche Onselaer; Alexander T Hardy; Clare Wilson; Ximena Sanchez; Amir K Babar; Jeanette L C Miller; Callum N Watson; Stephanie K Watson; Arkadiusz Bonna; Helen Philippou; Andrew B Herr; Diego Mezzano; Robert A S Ariëns; Steve P Watson
Journal:  Blood Adv       Date:  2017-08-15

6.  Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke.

Authors:  Valerie Tutwiler; Alina D Peshkova; Izabella A Andrianova; Dina R Khasanova; John W Weisel; Rustem I Litvinov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-01       Impact factor: 8.311

7.  Dominant role of αIIbβ3 in platelet interactions with cross-linked fibrin fragment D-dimer.

Authors:  Lorena Buitrago; Hina Zafar; Yixiao Zhang; Jihong Li; Thomas Walz; Barry S Coller
Journal:  Blood Adv       Date:  2020-07-14

Review 8.  Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Authors:  Alan Nurden
Journal:  J Blood Med       Date:  2021-07-08

9.  Fibrinogen as a Pleiotropic Protein Causing Human Diseases: The Mutational Burden of Aα, Bβ, and γ Chains.

Authors:  Elvezia Maria Paraboschi; Stefano Duga; Rosanna Asselta
Journal:  Int J Mol Sci       Date:  2017-12-14       Impact factor: 5.923

10.  Fibrin activates GPVI in human and mouse platelets.

Authors:  Osama M Alshehri; Craig E Hughes; Samantha Montague; Stephanie K Watson; Jon Frampton; Markus Bender; Steve P Watson
Journal:  Blood       Date:  2015-08-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.